SE8901566D0 - Nya peptider inkluderande en disulfidbindning - Google Patents

Nya peptider inkluderande en disulfidbindning

Info

Publication number
SE8901566D0
SE8901566D0 SE8901566A SE8901566A SE8901566D0 SE 8901566 D0 SE8901566 D0 SE 8901566D0 SE 8901566 A SE8901566 A SE 8901566A SE 8901566 A SE8901566 A SE 8901566A SE 8901566 D0 SE8901566 D0 SE 8901566D0
Authority
SE
Sweden
Prior art keywords
antigen
artificial
human parvovirus
epitope
amino acid
Prior art date
Application number
SE8901566A
Other languages
English (en)
Inventor
J Trojnar
Original Assignee
Ferring Diagnostica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Diagnostica Ab filed Critical Ferring Diagnostica Ab
Priority to SE8901566A priority Critical patent/SE8901566D0/sv
Publication of SE8901566D0 publication Critical patent/SE8901566D0/sv
Priority to PCT/SE1990/000276 priority patent/WO1990013567A1/en
Priority to CA002053240A priority patent/CA2053240A1/en
Priority to EP90908131A priority patent/EP0470205A1/en
Priority to AU55596/90A priority patent/AU636145B2/en
Priority to IL94218A priority patent/IL94218A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14211Erythrovirus, e.g. B19 virus
    • C12N2750/14222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8901566A 1989-04-28 1989-04-28 Nya peptider inkluderande en disulfidbindning SE8901566D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8901566A SE8901566D0 (sv) 1989-04-28 1989-04-28 Nya peptider inkluderande en disulfidbindning
PCT/SE1990/000276 WO1990013567A1 (en) 1989-04-28 1990-04-25 New human parvovirus peptides with disulfide bridge for immunization or diagnosis
CA002053240A CA2053240A1 (en) 1989-04-28 1990-04-25 Human parvovirus peptides with disulfide bridge for immunization or diagnosis
EP90908131A EP0470205A1 (en) 1989-04-28 1990-04-25 New human parvovirus peptides with disulfide bridge for immunization or diagnosis
AU55596/90A AU636145B2 (en) 1989-04-28 1990-04-25 New human parvovirus peptides with disulfide bridge for immunization or diagnosis
IL94218A IL94218A0 (en) 1989-04-28 1990-04-26 Peptides including a disulfide bond,their use in diagnosis and vaccine compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901566A SE8901566D0 (sv) 1989-04-28 1989-04-28 Nya peptider inkluderande en disulfidbindning

Publications (1)

Publication Number Publication Date
SE8901566D0 true SE8901566D0 (sv) 1989-04-28

Family

ID=20375840

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901566A SE8901566D0 (sv) 1989-04-28 1989-04-28 Nya peptider inkluderande en disulfidbindning

Country Status (6)

Country Link
EP (1) EP0470205A1 (sv)
AU (1) AU636145B2 (sv)
CA (1) CA2053240A1 (sv)
IL (1) IL94218A0 (sv)
SE (1) SE8901566D0 (sv)
WO (1) WO1990013567A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274307B1 (en) * 1990-02-08 2001-08-14 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active peptides or polypeptides from the parvovirus B19
US5244785A (en) * 1991-02-01 1993-09-14 Microgenics Corporation Determination of high molecular weight analytes using a β-galactosidase complementation assay
JPH0910000A (ja) 1995-06-26 1997-01-14 Nippon Sekijiyuujishiya ヒトパルボウイルスの検出方法及びそのための試薬
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70704A0 (en) * 1983-01-19 1984-04-30 Amgen Methods and materials for development of parvovirus vaccines
DE3782350D1 (de) * 1986-03-20 1992-12-03 Abbott Lab Rekombinante parvovirus-ra-1-produkte und verfahren zu deren anwendung.

Also Published As

Publication number Publication date
WO1990013567A1 (en) 1990-11-15
AU5559690A (en) 1990-11-29
EP0470205A1 (en) 1992-02-12
AU636145B2 (en) 1993-04-22
IL94218A0 (en) 1991-01-31
CA2053240A1 (en) 1990-10-29

Similar Documents

Publication Publication Date Title
ATE141286T1 (de) Hiv-peptide, künstliche hiv-antigene und immuntestsätze
Felsenfeld et al. Fine specificity mapping and topography of an isozyme-specific epitope of the Na, K-ATPase catalytic subunit.
BRPI0011369B8 (pt) método de detecção precoce e kit de diagnóstico precoce de uma infecção flaviviral, processo de purificação da proteína ns1 de um flavivírus,composição imunogênca,utilização da proteína ns1,de pelo menos um anticorpo monoclonal anti-ns1 e da proteína ns1 de forma hexamérica,e, processo de expressão de um polinucleotídeo codificado para a proteína ns1 de um vírus da dengue
DE69131149D1 (de) Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
DE68923882D1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
DE60333471D1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
KR920702688A (ko) Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로 부터 유도된 항체
FI913714A (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
Cho et al. Biochemical properties of a purified protein in cystic fluid of Taenia solium metacestodes
KR910007962A (ko) Hiv 관련 펩티드
DK312088A (da) Hidtil ukendte peptider og anvendelser deraf
KR970705578A (ko) 신규의 면역피임 펩티드류(new immunocontraceptive peptides)
DE69032009D1 (de) Peptide mit thiolgeschütztem cystein zur verwendung in immuntests
Winsnes Quantification of Tetanus Antitoxin in Human Sera: I. Counter‐Immunoelectrophoresis
BR9909308A (pt) Peptìdeo, ensaio para o diagnóstico de esquizofrenia em um indivìduo, e, kit para uso no diagnóstico de esquizofrenia
JPS6490197A (en) Peptide
ATE389175T1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
KR960037695A (ko) 전신홍반성 루푸스병의 진단에 사용될 수 있는 60kDa 및 52kDa Ro/SSA 항원의 항원결정기를 포함하는 펩티드
TH17011A (th) สารที่ใช้วินิจฉัย hcv ชนิดปรับปรุง